SummerHaven Investment Management’s Emergent Biosolutions EBS Stock Holding History

SummerHaven Investment Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,285	Closed	-$112K	–	216
2023 Q2	$112K	Sell	15,285 -11,715	-43%	-$109K	0.07%	194
2023 Q1	$280K	Buy	27,000 +1,653	+7%	+$20K	0.16%	197
2022 Q4	$299K	Buy	25,347 +914	+4%	+$14.1K	0.18%	199
2022 Q3	$513K	Buy	24,433 +9,957	+69%	+$277K	0.36%	193
2022 Q2	$449K	Hold	14,476	–	–	0.3%	170
2022 Q1	$594K	Buy	14,476 +662	+5%	+$29.2K	0.34%	177
2021 Q4	$600K	Hold	13,814	–	–	0.32%	193
2021 Q3	$692K	Buy	+13,814	New	+$837K	0.41%	187

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SummerHaven Investment Management's EBS Position: Q3 2023 in Review

SummerHaven Investment Management sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 15,285 shares — an estimated $112K sold.

SummerHaven Investment Management first reported a position in EBS in Q3 2021 and held it in 8 quarters. The position peaked at $692K in Q3 2021. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

SummerHaven Investment Management reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
SummerHaven Investment Management sold 15,285 Emergent Biosolutions shares in Q3 2023, an estimated $112K.
SummerHaven Investment Management first reported a position in Emergent Biosolutions in Q3 2021 and held it in 8 quarters.
SummerHaven Investment Management's Emergent Biosolutions position peaked at $692K in Q3 2021.
162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on SummerHaven Investment Management's 13F filing for Q3 2023, filed 13 Oct 2023.